MBOT
Income statement / Annual
Last year (2024), Microbot Medical Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Microbot Medical Inc.'s net income was $182,000.00.
See Microbot Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$117,000.00 |
| Cost of Revenue |
$0.00
|
$106,000.00
|
$102,000.00
|
$76,000.00
|
$68,000.00
|
$84,000.00
|
$54,000.00
|
$21,000.00
|
$10,000.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$106,000.00
|
-$102,000.00
|
-$76,000.00
|
-$68,000.00
|
-$84,000.00
|
-$54,000.00
|
-$21,000.00
|
-$10,000.00
|
$117,000.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
| Research and Development Expenses |
$6.63 M
|
$5.72 M
|
$7.74 M
|
$6.15 M
|
$3.40 M
|
$3.05 M
|
$2.52 M
|
$1.10 M
|
$1.11 M
|
$823,000.00
|
| General & Administrative Expenses |
$5.00 M
|
$4.13 M
|
$5.43 M
|
$5.10 M
|
$5.56 M
|
$4.03 M
|
$4.71 M
|
$4.14 M
|
$8.73 M
|
$92,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$120,000.00
|
$108,000.00
|
$130,000.00
|
$165,000.00
|
$23,000.00
|
$17,000.00
|
$36,000.00
|
$9.24 M
|
| Selling, General & Administrative Expenses |
$5.00 M
|
$4.13 M
|
$5.55 M
|
$5.20 M
|
$5.69 M
|
$4.19 M
|
$4.73 M
|
$4.16 M
|
$8.77 M
|
$9.33 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$230,000.00
|
| Operating Expenses |
$11.63 M
|
$9.86 M
|
$13.28 M
|
$11.36 M
|
$9.09 M
|
$7.24 M
|
$7.24 M
|
$5.27 M
|
$9.64 M
|
$915,000.00
|
| Cost And Expenses |
$0.00
|
$9.86 M
|
$13.28 M
|
$11.36 M
|
$9.09 M
|
$7.24 M
|
$7.24 M
|
$5.27 M
|
$9.64 M
|
$36.45 M
|
| Interest Income |
$0.00
|
$0.00
|
$54,000.00
|
$44.00
|
$80.00
|
$103.00
|
$0.00
|
$0.00
|
$0.00
|
$7,544.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$80,000.00
|
$103,000.00
|
$0.00
|
$238,000.00
|
$334,000.00
|
$506,319.00
|
| Depreciation & Amortization |
$0.00
|
$106,000.00
|
$102,000.00
|
$76,000.00
|
$68,000.00
|
$84,000.00
|
$54,000.00
|
$21,000.00
|
$10,000.00
|
$17,000.00
|
| EBITDA |
$0.00 |
-$10.63 M |
-$13.18 M |
-$11.28 M |
-$9.02 M |
-$7.16 M |
-$7.17 M |
-$5.25 M |
-$9.63 M |
-$897,000.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-7.67
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-7.82
|
| Total Other Income/Expenses Net |
$0.00
|
-$885,000.00
|
$113,000.00
|
$44,000.00
|
-$80,000.00
|
-$7,000.00
|
-$16,000.00
|
-$2.32 M
|
-$28,000.00
|
-$6,000.00
|
| Income Before Tax |
$182,000.00
|
-$10.74 M
|
-$13.17 M
|
-$11.31 M
|
-$9.17 M
|
-$7.25 M
|
-$7.26 M
|
-$7.59 M
|
-$9.66 M
|
-$921,000.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-7.87
|
| Income Tax Expense |
$182,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$20,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$182,000.00
|
-$10.74 M
|
-$13.17 M
|
-$11.31 M
|
-$9.17 M
|
-$7.25 M
|
-$7.26 M
|
-$7.59 M
|
-$9.66 M
|
-$921,000.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-7.87
|
| EPS |
0.0116 |
-1.05 |
-1.81 |
-1.59 |
-1.29 |
-1.7 |
-2.49 |
-3.48 |
-10.14 |
-7.2 |
| EPS Diluted |
0.0116 |
-1.05 |
-1.81 |
-1.59 |
-1.29 |
-1.7 |
-2.49 |
-3.48 |
-10.14 |
-7.2 |
| Weighted Average Shares Out |
$15.64 M
|
$10.20 M
|
$7.26 M
|
$7.11 M
|
$7.12 M
|
$4.27 M
|
$3.01 M
|
$2.18 M
|
$952,886.00
|
$73,237.00
|
| Weighted Average Shares Out Diluted |
$15.64 M
|
$10.20 M
|
$7.26 M
|
$7.11 M
|
$7.12 M
|
$4.27 M
|
$3.01 M
|
$2.18 M
|
$952,886.00
|
$73,237.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
